Circulating myostatin levels as a prognostic biomarker in patients with acute liver failure and late-onset hepatic failure.

Manabu HayashiKazumichi AbeTatsuro SugayaYosuke TakahataMasashi FujitaAtsushi TakahashiHiromasa Ohira

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2024)

Low serum myostatin levels were associated with a low psoas muscle index, complication rate, and poor prognosis in patients with ALF and LOHF. Assessment of circulating myostatin levels may improve the prediction of outcomes in patients with ALF and LOHF.

Keyphrases

poor prognosis
late onset
liver failure
long non coding rna
early onset
hepatitis b virus
skeletal muscle
type diabetes
adipose tissue
weight loss